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Abstract
Amyloid precursor protein (APP) is a transmembrane glycoprotein frequently studied for its role in Alzheimer’s disease. Our
recent study in APP knockout (KO) mice identified an important role for APP in modulating normal neuronal development in
the retina. However the role APP plays in the adult retina and whether it is required for vision is unknown. In this study we
evaluated the role of APP in retinal function and morphology comparing adult wildtype (WT) and APP-KO mice. APP was
expressed on neuronal cells of the inner retina, including horizontal, cone bipolar, amacrine and ganglion cells in WT mice.
The function of the retina was assessed using the electroretinogram and although the rod photoreceptor responses were
similar in APP-KO and WT mice, the post-photoreceptor, inner retinal responses of both the rod and cone pathways were
reduced in APP-KO mice. These changes in inner retinal function did not translate to a substantial change in visual acuity as
assessed using the optokinetic response or to changes in the gross cellular structure of the retina. These findings indicate
that APP is not required for basic visual function, but that it is involved in modulating inner retinal circuitry.
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Introduction
Amyloid precursor protein (APP) is a type I transmembrane
glycoprotein that is endogenously expressed in the brain and retina
[1]. APP is well known for its role in pathology, as its cleavage
product Ab peptide is the key component of amyloid plaques in
Alzheimer’s disease [2,3]. However, the normal function of APP in
the central nervous system remains to be clarified. APP transgenic
and APP knockout (KO) mouse models indicate that APP has
physiological functions involving modulation of neurite outgrowth
[4], synaptic activity [5,6,7], regulation of metal homeostasis
[8,9,10], synaptic transmission [11] and synaptic adhesion at the
neuromuscular junction [12].
We have reported that APP plays a role in retinogenesis, as
APP-KO mice have changes in retinal cell development. In
particular, differentiation of some inner retinal neurons, specifi-
cally horizontal and amacrine cells are hampered in APP-KO
mice during early postnatal development [13]. By adulthood APP-
KO mice have normal numbers of horizontal cells and most types
of amacrine cells. However, the number of AII amacrine cells,
which are important for rod pathway function, are still reduced in
the adult APP-KO retina [13]. We hypothesised that these
alterations in retinal cell development may affect signalling in the
adult APP-KO mouse. Therefore, we investigated the role of APP
in the retina by assessing the function of the rod and cone
pathways separately using the electroretinogram (ERG) and
general visual function using the optokinetic response. We further
characterised the cellular location of APP in the adult retina and
the effect of APP deficiency on retinal morphology.
Methods
Animals
Mice were housed in the Biomedical Sciences Animal Facility at
The University of Melbourne. Adult APP-KO mice [14] and age-
matched wild type (WT) C57/Bl6J6SV129 control mice at 1, 3,
and 12 months of age were used. Mice were housed with ad libitum
access to food and water under a 12 h:12 h light-dark cycle. All
experiments involving animals were approved by the University of
Melbourne animal experimentation ethics committee, Ethics ID
numbers: 0911158 & 1011059. In addition, experiments adhered
to the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research. For in vivo experiments, mice were
anaesthetised by intra-peritoneal administration of a mixture of
ketamine (67 mg/kg) and xylazine (13 mg/kg). For all procedures
involving tissue collection, mice were first anesthetised (as above)
and euthanized by cervical dislocation.
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Immunohistochemistry was used to determine the neuron
specific location of APP in normal retina and to determine
whether retinal morphology was altered in the APP-KO using
previously published techniques [15]. Briefly posterior eyecups
were fixed for 30 minutes in 4% paraformaldehyde, washed in
0.1 M phosphate buffer, pH 7.4 (PB) and then cryoprotected in
graded sucrose solutions. Eyes were embedded in OCT compound
(Tissue-Tek, California, USA) and transverse sections of the
eyecup were cut with a Microm HM550 cryostat (Microm,
Walldorf, Germany) at 220uC, at a section thickness of 14 mm.
Sections were mounted onto PolysineH glass slides (PolysineH
Adhesion slides, Thermo Scientific, VIC, Australia) and stored at
220uC until processing.
For staining, thawed sections were washed in PB and non-
specific binding sites were blocked (10% Normal goat serum
(NGS), 1% Bovine serum albumin, 0.5% Triton X-100, in PB) for
1 hour. The sections were incubated with primary antibodies
overnight (Table 1). After washing in PB, sections were incubated
with secondary antibody: goat anti-guinea pig, goat anti-mouse,
goat anti-rabbit or donkey anti-sheep conjugated to AlexaFluor
488, AlexaFluor 594 or AlexaFluor 643 (Invitrogen, VIC,
Australia; diluted 1:500) as required, for 90 minutes. The sections
were washed and cover slipped. Two different antibodies were
used to localise APP expression in the adult mouse retina; CT20,
(rabbit anti-APP; Calbiochem, Merck Australia), which was
generated against the C-terminal region of the APP peptide and
22C11, (mouse anti-APP; Millipore, Invitrogen Australia), which
was generated against the N-terminal region of the APP peptide.
Preliminary studies with these antibodies indicated that while the
CT20 antibody produced specific labelling in WT but not APP-
KO mouse retina, the 22C11 antibody labelled similarly in both.
In particular, 22C11 labelled retinal glia, the Mu ¨ller cells, in both
WT and APP-KO mouse retina. This indicates that the antibody,
22C11, generated against the N-terminal epitope of APP could not
be used to specifically evaluate APP expression in the retina,
possibly because it binds another protein with a similar N-
terminal, APLP2, and not just APP [16]. However, as the CT20
antibody was specific for APP in the retina all further experiments
were completed using this antibody. For immunohistochemical
localisation of APP on retinal ganglion cells, Thy1-HYFP mice,
which have subpopulations of ganglion cells that produce yellow
fluorescent protein in cells which express the thy-1 promoter, were
used [17]. These mice were kindly donated by A/Prof Anthony
Hannan (Howard Florey Institute, Vic, Australia) and bred at the
University of Melbourne.
Images were taken using the LSM 5 Pascal confocal laser
scanning microscope (Zeiss, Oberkochen, Germany) using a 40x/
1.3 oil-immersion objective at a resolution of 102461024 pixels.
Gain settings were at the same level when taking images for WT
and APP-KO tissue sections. Magnifications varied, with scale
bars digitally added to the images by Zeiss LSM Image Browser
software (v4.2.0.121, Zeiss, Oberkochen, Germany). Images from
WT and APP-KO mice were adjusted for black levels, contrast
and brightness in Adobe Photoshop CSE version 4 (Adobe
Systems, CA, USA) using the same settings for consistency
between samples.
Visual function of WT and APP-KO mice
Electroretinography (ERG) and component analysis:
The ERG was used to assess the function of the rod and cone
pathways of 3 month old WT and APP-KO mice using previously
published techniques [15]. Mice were dark adapted overnight and
anesthetised under dim red light. Pupils were dilated with
tropicamide (Mydriacyl 0.5%, Alcon Laboratories, Austral ia)
and the cornea was anaesthetised with proxymetacaine (Alcaine
0.5%, Alcon Laboratories, Australia). ERG responses were
recorded with custom-made silver-silver chloride (Ag-AgCl)
electrodes, with a corneal active electrode that measured the
summed response with reference to an inactive electrode hooked
onto the front teeth.
ERGs were elicited with full-field flashes of 2.1 log cd.s/m
2
intensity (Nikon SB900, NSW, Australia), presented with a custom
Ganzfeld sphere. The rod and cone responses were isolated using a
twin-flash paradigm with a 0.8 s interstimulus interval [18,19].
Responses were amplified (gain65000; 23 dB at 1 Hz and 1 kHz,
ADInstruments, NSW, Australia) and digitized at 10 kHz. Stimuli
and ERG recordings were coordinated using Scope v3.6.9
program software.
Rod response: The rod photoreceptor response of the ERG is
represented by the cornea negative a-wave. It was fitted to a
modified version of the PIII model [20]:
PIII i|t ðÞ ~1{exp 0:5|{i|S| t{td ðÞ
2
hi
|Rmax
where PIII (mV) is the summed rod photocurrent as a function of
luminous energy, i (cd.s.m
22) and time, t (seconds). Sensitivity, S
Table 1. Primary antibodies used for immunohistochemical analysis.
Cell type/Target Antibody Dilution Source Reference
APP Rabbit anti-APP CT20 1:1000 Calbiochem (Merck), VIC, Australia [56,57]
APP and N-terminal Mouse anti-APP 22C11 1:100 Millipore, North Ryde, NSW, Australia [13,58]
Horizontal cells Mouse anti-Calbindin D28k 1:4000 Swant, Bellinzona, Switzerland [59]
Rod Bipolar cells Mouse anti-PKCa 1:400 Sigma-Aldrich, NSW, Australia [60]
Cone-ON& OFF Bipolar cells Mouse anti-ZNP-1 1:2000 ZIRC, Eugene, Oregon, USA [61]
Amacrine cells Mouse anti-Calretinin 1:1000 Swant, Bellinzona, Switzerland [62]
GABAergic amacrine cells Guinea pig anti-GABA 1:500 Millipore, NSW, Australia [62]
Ganglion and GABAergic
amacrine cells
Mouse anti-NeuN 1:500 Millipore, NSW, Australia [63]
Ganglion cells Goat anti-GFP (for YFP under Thy1
promoter)
1:500 Rockland, SA, Australia [17]
doi:10.1371/journal.pone.0029892.t001
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21s
23) represents the gain of phototransduction cascade with
a time delay, td (seconds) that accounts for the brief latency
between stimulus presentation and recording of response.
The positive b-wave reflects post-photoreceptoral function and
was isolated by subtraction of the rod PIII from the raw rod
waveform and then fitted using an inverted gamma function to
generate the rod PII [21]:
Rt ðÞ ~Rmax
c
dz1 ðÞ t{Tmax ðÞ zc
   dz1
|exp
t{Tmax ðÞ dz1 ðÞ
2
dz1 ðÞ t{Tmax ðÞ zc
"#
From the rod PII the response amplitude Rmax (mV) and time to
peak, t (milliseconds (ms)) after the flash onset were calculated. The
parameters for the equation include: the peak amplitude, Rmax
(mV), the implicit time until the maximum amplitude, Tmax (ms),
and constants, c and d, are factors that affect the shape of the
curve.
The Oscillatory potentials (OPs) are thought to primarily reflect
the excitatory and inhibitory activities of the amacrine cells [22].
They were isolated from the ascending limb of the b-wave by
subtracting the fitted rod PII from the raw rod waveform. OP2,
OP3 and OP4 were analysed to assess their amplitude (mV) and
their implicit time (ms). OP1 and OP5 were not assessed as they
are difficult to consistently distinguish from noise due to their small
amplitude.
Cone response: The cone a-wave of the mouse is too small to
be analysed, due to the small number of cone photoreceptors as
compared to the rod photoreceptors. Nevertheless, the cone post-
receptoral response (cone b-wave) could be assessed and the cone
PII was analysed by fitting the inverted gamma function (above) to
the raw cone waveform. The maximum amplitude response, Cone
PII amplitude (mV), and the time when this was reached, implicit
time (ms) were assessed.
In vivo, visual spatial threshold measurements: Visual
function was assessed in live, behaving animals using a virtual
optomotor system (OptoMotry 1.7.4.3 [23]). The optokinetic
response of WT and APP-KO mice under light adapted conditions
was determined in response to sine wave gratings presented at
100% contrast. Spatial frequency thresholds were determined
using a simple staircase protocol that varied the spatial frequency
of gratings rotating at a constant velocity (12 deg s
21). Using a
two-alternative, forced-choice protocol, the observer would choose
the direction of grating rotation (right or left) according to the
mouse’s head movements. The average spatial frequency cutoff
(cycles/degree) was defined as the highest spatial frequency that
elicited a reliable head tracking response. Mice were tested at a
photopic mean luminance (100 cd m
22). All measurements were
made by an observer blind to stimulus condition.
Statistical analysis
Results are expressed as the mean 6 the standard error of the
mean (SEM). Spatial frequency threshold across ages (1, 3 and 12
months) and genotype (WT vs. APP-KO) were analysed by two-
way, analysis of variance (2-way ANOVA), and a Bonferroni post-
hoc test was used to analyse the effect of genotype at individual
ages (Graphpad Prism v.4, San Diego, CA, USA). ERG responses
between WT and APP-KO mice at 3 months were compared
using an unpaired Student’s t-test. In all figures, statistical
significance is expressed as *P,0.05, **P,0.01, and ***P,0.001.
Results
APP is expressed in the inner neural retina of the WT
mouse
The APP antibody, CT20 binds to the intracellular C-terminal
domain of APP and we confirmed its specificity for APP in
transverse sections of neural retina from three month old WT and
APP-KO mice. In WT neural retina, CT20 labelled cells of the
inner nuclear layer (INL) and ganglion cell layer (GCL) but not
photoreceptor nuclei in the outer nuclear layer (ONL; Figure 1A).
Figure 1. The antibody CT20 detects APP-immunoreactive protein in WT but not APP-KO retina. (A) Immunohistochemistry on a
transverse retinal section from an adult WT mouse shows CT20 labels APP immunoreactivity in the outer plexiform layer (OPL), inner nuclear layer
(INL), inner plexiform layer (IPL) and ganglion cell layer (GCL) but not in the outer nuclear layer (ONL). (B) The APP-KO retina does not label with the
CT20 antibody, suggesting that the antibody is specific for APP in retinal sections. Scale, 20 microns.
doi:10.1371/journal.pone.0029892.g001
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detected in the retina in the absence of APP (Figure 1B). This
finding indicates that the CT20 antibody can be used to
specifically detect APP expression in the retina by immunohisto-
chemistry.
To determine the retinal cell types that express APP in the adult
WT mouse, we performed double labelling experiments with
CT20 and known retinal cell markers. Given the lack of CT20
labelling in the outer nuclear layer, we restricted our cellular
analysis to the inner retinal neurons. Horizontal cells, labelled
using an antibody against calbindin, were APP immunoreactive
(Figure 2A–C), however, rod bipolar cells labelled with PKCa
(Figure 2D–F) were not APP immunoreactive. Cone bipolar cells,
specifically type 2-OFF and type 6-ON labelled with ZNP-1
(Figure 2G–I), co-localised with CT20 indicating that subpopula-
tions of cone bipolar cells express APP. Amacrine cells, both
calretinin-positive (Figure 3A–C) and GABA-positive (Figure 3D–
F), were APP-immunoreactive, confirming our previous report of
amacrine cell expression of APP [13]. To assess ganglion cells, we
used a transgenic mouse where YFP expression is driven by the
Thy-1 promoter in a subpopulation of ganglion cells (HYFP-thy1;
[17]) and found CT20 co-localised with GFP positive ganglion
cells (Figure 3G–I).
The co-localisation studies demonstrate that APP is expressed
by virtually all neuronal cell types in the inner retina with the
exception of rod bipolar cells in the adult mouse. Based on these
findings, we predict that the lack of APP expression in APP-KO
mice could affect inner retinal function.
Rod pathway function is altered in the APP-KO mouse
To assess the function of APP in the retina, the rod and cone
ERGs from three month old WT and APP-KO mice were
recorded. The rod and cone ERG waveforms represent a measure
of the summed electrical responses of populations of retinal
neurons in response to a flash of light. As such the ERG can be
used as a measure of function of each of these neuronal
populations. Figure 4A shows that the representative rod ERG
waveform of APP-KO mice is altered when compared with the
response recorded from WT mice. The rod photoreceptor
response (PIII amplitude; a-wave; Figure 4B) of the APP-KO
mice (354.40612.14 mV, n=14) was similar to that of the WT
mice (386.10615.75 mV, n=16; P=0.19). Moreover, the sensi-
tivity parameter of the rod PIII (Figure 4C) that represents the
kinetics of rod phototransduction, was not significantly different
between the two genotypes (WT: 29486186.10 m
2cd
21s
23,
n=16; APP-KO: 32236302.70 m
2cd
21s
23, n=14; P=0.12).
In contrast, the rod b-wave amplitude (rod PII), which repre-
sents inner retinal function primarily the rod bipolar cell res-
ponse [24,25], was significantly reduced in the APP-KO mice
(480.0621.11 mV, n=14) compared to the WT mice
(552.20620.28 mV, n=16; P=0.02) (Figure 4D). However, the
implicit time of this response was indistinguishable between APP-
Figure 2. APP-immunoreactivity (IR) in the WT mouse retina colocalises with horizontal cells and cone bipolar cells but not rod
bipolar cells. Immunohistochemistry on a transverse retinal section from an adult WT mouse for (A) horizontal cells labelled with Calbindin, and (B)
APP-IR, showing (C) colocalisation. Immunohistochemistry for (D) rod bipolar cells labelled with PKCa and (E) APP-IR, showing that the markers do not
colocalise (F). Immunohistochemistry for (G) cone bipolar cells (Type 2 and 6) labelled with a ZNP-1 and (H) APP-IR, showing (I) colocalisation. Arrows
indicate examples of colocalisation. Outer plexiform layer (OPL), inner nuclear layer (INL), inner plexiform layer (IPL) and ganglion cell layer (GCL).
Scale, 50 microns.
doi:10.1371/journal.pone.0029892.g002
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(OPs) extracted from the leading edge of the b-wave (Figure 4E)
are thought to primarily reflect the functions of the amacrine cells
[22,26]. The average response amplitudes of the individual OPs
were significantly greater in APP-KO mice (OP2: 35.7365.04 mV;
OP3: 215.9067.69 mV; OP4: 162.9068.40 mV; n=14) than in
WT mice (OP2: 67.8865.88 mV, P,0.01; OP3: 157.3069.09 mV,
P,0.001; OP4: 118.9066.65 mV, P,0.001; n=16) (Figure 4F).
However, there was no change in the timing of the OPs between
these genotypes (data not shown). These data indicate APP is not
important for rod photoreceptor function but that it is involved in
modulating transmission of the inner retinal rod pathway response
in adult mice.
Cone pathway function is altered in the APP-KO mouse
Representative cone ERG waveforms for APP-KO and WT
mice, generated in response to the second flash of the twin-flash
ERG, are presented in Figure 5A. The cone a-wave of the mouse
is too small to be analysed, due to the small number of cone
photoreceptors as compared to the rod photoreceptors. However,
we could measure the cone b-wave, which has been proposed to
reflect the activity of the cone depolarising bipolar cells in the INL
[27,28]. The cone b-wave amplitude (cone PII) was significantly
smaller in the APP-KO mice (172.30615.62 mV; n=14) than in
the WT mice (241.70614.84 mV; n=16) (Figure 5B). However,
similar to the other kinetic parameters measured for the rod
pathway, the cone PII implicit time was similar between the two
genotypes (data not shown). These data suggest APP plays a role in
cone pathway function in the mouse retina.
Given the prominent differences obtained from the ERG
responses, we wanted to further identify whether APP-KO mice
had functional deficits that may affect their visual acuity. This was
assessed using the OptoMotry system, where the ability of the mice
to track gratings of various widths was quantified by the
optokinetic reflex and measured as the spatial frequency threshold,
or visual acuity [29]. This test was performed under light adapted
conditions; hence the response would primarily be due to functions
of the cone pathway and in particular amacrine cells that are
sensitive to changes in direction/lateral movement [30,31,32,33].
The spatial frequency thresholds of WT and APP-KO mice were
compared at one month (WT: 0.5060.02 cyc/deg, n=10; APP-
KO: 0.5160.02 cyc/deg, n=8), three months (WT: 0.4960.04
cyc/deg, n=16; APP-KO: 0.5460.03 cyc/deg, n=14) and twelve
months (WT: 0.4560.04 cyc/deg, n=13; APP-KO: 0.5160.01,
n=10) of age (Figure 5C). A two-way ANOVA was performed to
analyse the effects of age and genotype on spatial frequency
threshold and although there was no significant effect of age
(P=0.162), there was a small but significant effect of genotype
(P=0.023). When a post-test analysis was used to compare the
spatial frequency threshold of APP-KO and WT mice at each
individual age, no significant differences were found at any specific
age (Bonferroni post-test, 1 month P.0.05, 3 months P.0.05 and
12 months P.0.05). As the spatial frequency thresholds of WT
and APP-KO mice were at a physiological level statistically
Figure 3. APP-immunoreactivity (IR) in the WT mouse retina colocalises with with calretinin positive- and GABA positive-amacrine
cells, as well as ganglion cells. Immunohistochemistry on a transverse retinal section from an adult WT mouse for (A) amacrine cells labelled with
Calretinin, and (B) APP-IR, showing (C) colocalisation. Immunohistochemistry for (D) GABAergic amacrine labelled with an antibody against GABA and
(E) APP-IR, showing (F) colocalisation. Immunohistochemistry for (G) ganglion cells labelled with an antibody against GFP to localise YFP positive cells
in the thy1-HYFP mouse and (H) APP-IR, showing (I) colocalisation. Arrows indicate examples of colocalisation, while * indicates a calretinin positive
cell not labelled for APP-IR. Inner nuclear layer (INL), inner plexiform layer (IPL) and ganglion cell layer (GCL). Scale, 50 microns.
doi:10.1371/journal.pone.0029892.g003
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from dark adapted, 3 month old WT (black) and APP-KO (grey) mice in response to a 2.1 log cd.s/m
2 intensity flash. The photoreceptor derived, rod
PIII was not altered in either (B) amplitude or (C) sensitivity in the APP-KO mouse when compared with the WT response. The post-photoreceptor
response, the rod PII (D) was significantly smaller in amplitude in the APP-KO mouse. (E) Representative waveforms of the oscillatory potentials (OPs)
extracted from rod ERG in WT (n=16) and APP-KO (n=14) mice. (F) All of the inner retinal derived OPs measured were significantly enhanced in the
APP-KO mouse. Results expressed as mean +/2 SEM, *, p,0.05, **, p,0.01; ***, p,0.001.
doi:10.1371/journal.pone.0029892.g004
Figure 5. The function of the cone pathway is altered in the APP-KO mouse. (A) Representative waveforms of the cone ERG recorded from 3
month old WT (black) and APP-KO (grey) mice in response to the second flash of a twin flash paradigm ERG (2.1 log cd.s/m
2 flash intensity). (B) The
cone pathway post-photoreceptor response, the cone PII was found to be smaller in amplitude in APP-KO mice when compared with the WT
response. (C) The photopic visual acuity, assessed using the optokinetic reflex to determine the spatial frequency threshold, was physiologically
similar between APP-KO and WT mice with age. Results expressed as mean +/2 SEM. **, p,0.01.
doi:10.1371/journal.pone.0029892.g005
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of this visual response.
Based on the significant differences in ERG b-waves, and OP
amplitudes between WT and APP-KO mice, we conclude that
APP has a functional role on the rod and cone pathways, where it
is involved in modulating bipolar and amacrine cell functions in
the inner retina. These functional findings are consistent with the
cellular location of APP immunoreactivity in the retina.
Inner retinal neuron profiles are similar in three month
old WT and APP-KO mice
To assess if the differences in ERG b-wave and OP amplitude
were due to gross morphological changes in the retina, inner
retinal cell markers were used to assess the morphology of the
specific cells classes that usually express APP. There were no
prominent differences in the labelling profiles of horizontal cells
(WT, Figure 6A; APP-KO, Figure 6B), rod bipolar cells (WT,
Figure 6C; APP-KO, Figure 6D), type 2-OFF and type 6-ON cone
bipolar cells (WT, Figure 6E; APP-KO, Figure 6F), calretinin-
positive amacrine cells (WT, Figure 6G; APP-KO retina,
Figure 6H), GABAergic amacrine cells (WT, Figure 6I; APP-
KO, Figure 6J) and lastly ganglion cells labelled in conjunction
with GABAergic amacrine cells using the marker NeuN (WT,
Figure 6K; APP-KO, Figure 6L). In our previous study, we
showed that INL thickness was subtly but significantly reduced at
postnatal day 30 in APP-KO mice [13]. Therefore, further
analysis such as quantification of cell or synapse number or
morphological analysis of cell structure would be required to
identify any subtle changes in the cells that usually express APP, in
order to explain the significant functional ERG changes observed
between WT and APP-KO mice.
Figure 6. The number and morphology of inner retinal neurons is similar in adult WT and APP-KO mice. Immunohistochemistry using
various cell markers was used to probe for gross changes in retinal cell classes in the APP-KO mice. Similar cell profiles were observed for: horizontal
cells labelled with Calbindin in (A) WT and (B) APP-KO; rod bipolar cells labelled with PKCa in (C) WT and (D) APP-KO mice; cone bipolar cells (type 2
and 6) labelled with ZNP-1 in (E) WT and (F) APP-KO mice; calretinin-positive amacrine cells in (G) WT and (H) APP-KO mice; GABAergic amacrine cells
labelled for GABA in (I) WT and (J) APP-KO mice and; ganglion cells and GABAergic amacrine cells labelled with NueN in (K) WT and (L) APP-KO mice.
Outer nuclear layer (ONL), outer plexiform layer (OPL), inner nuclear layer (INL), inner plexiform layer (IPL) and ganglion cell layer (GCL). Scale,
50 microns.
doi:10.1371/journal.pone.0029892.g006
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While APP is important in retinal development, its role in
modulating retinal function and structure in the adult mouse is
unknown. In the current study, we demonstrate that in the adult
mouse APP is specifically expressed on neuronal cells in the inner
retina and that a lack of APP expression causes significant
alterations in the inner retinal function of the rod and cone
pathways. However, these changes in retinal function do not
translate to a substantial change in visual acuity under light
adapted conditions or to changes in the gross cellular structure of
some cell classes in the retina. These findings indicate that APP is
not required for basic visual function, but rather that it modulates
the inner retinal circuitry.
APP is expressed by neurons of the inner retina of the
adult mouse but is not critical for their maintenance
APP expression in the brain is essential for a number of
physiological functions [8,9,10,11,34,35]. In the eye, APP is
expressed in the developing and mature retina and is important for
development of retinal cell classes and architecture [2,13,36]. To
further explore the expression profile of APP in the adult mouse
neural retina we used immunohistochemistry with the anti-APP
antibody, CT20, to show that APP is expressed on neurons of the
inner nuclear layer and ganglion cell layer but not in the outer
nuclear layer of the WT mouse. This result is generally consistent
with other studies in the retina of the rat [37], human [38] and
mouse [13,36]. In our previous study, APP mRNA was detected in
the outer nuclear layer in photoreceptor nuclei using in situ
hybridisation [13]. In the current study we did not see APP protein
in photoreceptor nuclei using immunocytochemistry, however
labelling was present in the outer plexiform layer where the
protein may be present on the photoreceptor terminals. Moreover,
our findings extend on our previous work to show that APP is
expressed on horizontal, type 2 cone-OFF bipolar, type 6 cone-
ON bipolar, calretinin-positive amacrine, GABAergic amacrine
and ganglion cells. The only inner retinal cell types analysed that
did not express APP were the rod bipolar cells. This suggests that
APP may play a role in the function of specifically horizontal, cone
bipolar, amacrine and ganglion cells in the adult WT mouse
retina.
Although APP may play a role in the function of these inner
retinal neurons, it is not critical for their ongoing survival.
Immunohistochemistry for specific retinal cell markers showed
that the cell classes that usually express APP were present in both
WT and APP-KO retinal tissue and that the morphology of these
cells was qualitatively similar between the two genotypes. This
suggests that although during early postnatal development there
are changes in amacrine cell numbers in APP-KO compared to
WT retina, by adulthood, with the exception of the AII amacrine
cells, this difference is no longer observed [13]. This may, in part,
be explained by the potential for other peptides, such as amyloid
beta precursor-like proteins 1 and 2 (APLP1 and APLP2) to
compensate for the role of APP during development and in the
adult APP-KO mouse [39]. However, studies in the brain of APP-
KO mice indicate APP is involved in neurite outgrowth [4] and
modulation of synaptic activity [5,6,7,11], as well as being
important in synaptic adhesion [12]. If APP plays a similar role
in the retina then our findings indicate that APP may be important
for synaptic fidelity between inner retinal neurons.
APP is involved in modulating inner retinal function
The role of APP on the individual components of the rod and
cone pathways was assessed using the twin-flash ERG. The rod
pathway response of WT and APP-KO mice showed that there
was no change in the rod photoreceptor response parameters
between the two genotypes. This suggests that there are no
significant changes to the number and/or length of the rod outer
segments, and no changes in the photoreceptor phototransduction
cascade in the APP-KO mice [21,40]. In contrast, the rod
pathway inner retinal responses were significantly different
between APP-KO and WT mice. There was a decrease in rod
b-wave and an increase in oscillatory potential amplitude in the
APP-KO compared to WT mice. Changes in the rod b-wave have
been attributed to dysfunction of photoreceptor neurotransmission
[41], and dysfunction of rod bipolar cells [24,25] and/or amacrine
cells [42,43], while changes in oscillatory potential amplitude have
been attributed primarily to alterations in amacrine cell responses
[22,42,43]. Given our immunohistochemical analysis showed that
APP is not expressed on rod bipolar cells in the mouse retina, it is
unlikely that the changes in the APP-KO rod b-wave are due to
alterations of rod bipolar cell function. Rather, it is likely that the
rod b-wave is affected by changes in either photoreceptor
neurotransmission or alterations in lateral inhibition from the
horizontal or amacrine cells. Indeed the rod ERG phenotype
observed in APP-KO mice is very similar to that of mice lacking
normal lateral inhibition driven by the GABAC receptor [42]. This
indicates that the changes in inner retinal function observed in the
APP-KO mouse may reflect an alteration in the activity of
inhibitory GABAergic amacrine cells, (eg. A17 amacrine cell)
which provide feedback to modulate the output of rod bipolar cells
[43,44]. The decrease in cone b-wave amplitude in the APP-KO
could be via a similar mechanism to that observed for the rod
pathway or via direct alteration to the responses of the cone-
bipolar cells themselves [27,28] given that our findings indicate
they usually express APP in the WT mouse.
In contrast to our ERG findings, we found that visual acuity was
only subtly different between WT and APP-KO mice across all
ages. Considering the substantial changes in the ERG response of
the APP-KO mice, an explanation for their relatively normal
visual acuity is unclear, but it is likely that the two techniques are
assessing the function of different components in the retina. The
visual acuity test, under light-adapted conditions, involves the
optokinetic eye movement reflex and has been suggested to reflect
the direction selective function of the starburst amacrine cells
[30,31,32,33], which are unlikely to be stimulated by the
stationary flash ERG test. This suggests that APP is not likely to
be critical for the development and maintenance of the direction
selectivity response of cholinergic/GABAergic starburst amacrine
cells. It is possible that APP may only play a role in select amacrine
cell pathways within the retina where it might regulate activity by
modulating development and synaptic connectivity of certain
amacrine classes more so than others. For example, our study and
others, implicate a role for APP in modulating the function of
amacrine cells in the ‘‘through’’ pathway, eg the GABAergic A17s,
which feedback on to rod bipolar cells [42,44] and the AII
amacrine cell [13], while in contrast the function of more complex
lateral pathways such as those driven by directionally selective,
starburst amacrine cells [45] are less likely to be altered. Our
findings indicate that APP is unlikely to be required for basic visual
function involved in directional selectivity, but that it may be
involved in other modulations of the inner retinal circuitry as
indicated by changes in the ERG.
Implications for Alzheimer’s disease and visual function
in humans
There is a mounting body of literature correlating Alzheimer’s
disease with visual disturbances ([46] for review), retinal ganglion
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and also glaucoma [51]. In animal models of glaucoma, the
formation of Ab peptides through cleavage of APP has been
reported to be involved in the mechanisms underlying ganglion
cell apoptosis [52,53,54]. In addition, in animal models of
Alzheimer’s disease, in which mutant human APP is expressed,
the effect of toxic Ab peptide has been assessed in the retina
[2,36,55]. These studies found that toxic Ab peptide was present in
the retina [36] and in the ganglion cell layer, and one study found
it to be associated with ganglion cell death [2]. Unfortunately,
reports confirming the role of APP and Ab peptides in the normal
retina and in the retina of patients with Alzheimer’s disease are
limited [46]. Our findings with the APP-KO mouse model suggest
that APP, or downstream effectors of APP, may be important
specifically for inner retina function. Thus, changes in the
regulation of retinal APP could contribute to the visual
disturbances reported in patients with Alzheimer’s disease.
Conclusion
In conclusion, by utilising a range of functional and histological
techniques, we found APP is expressed on inner retinal neurons
and that it is required for the inner retinal function of the rod and
cone pathway in the adult mouse. However, APP is not required
for gross retinal architecture or photopic visual acuity. Our
findings indicate that APP is required for normal inner retinal
function and provide an insight into the role of APP in the adult
retina.
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